Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: EBMT Global Committee statement on worldwide priorities for hematopoietic transplantation and cellular therapy

  • By

  • Arnon Nagler

  • Norbert Claude Gorin

  • Christian Chabannon

  • Guillermo Puigventós

  • Romée Heemskerk

  • Isabel Sánchez-Ortega

  • Tuula Rintala

  • Yann Mahé

  • Emanuele Angelucci

  • Silvia Montoto

  • Michelle Kenyon

  • Hilda Mekelenkamp

  • Donal P. McLornan

  • Antonio M. Risitano

  • Mette Hazenberg

  • Anna Sureda

  • Ibrahim Yakoub Agha

  • Annalisa Ruggeri

  • Fabio Ciceri

  • Raffaella Greco

  • October 12, 2026

Share

Objective:

The article examines the objective, findings, and clinical context described in Correction: EBMT Global Committee statement on worldwide priorities for hematopoietic transplantation and cellular therapy.

Approach:
  • Correction: The correction adds wording to paragraph four of the Methods section concerning approval by the EBMT Board of Directors and compliance with relevant requirements.
Key Findings:
  • The correction was published online on 11 August 2026.
  • The original article has been corrected.
Interpretation:

The correction concerns the Methods section; the supplied context does not specify the full wording added.

Limitations:
  • The context provides only a partial description of the inserted text.
  • No source URL was provided.
Sources:

Original Source(s)

Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee

  • by Arnon Nagler, Norbert Claude Gorin, Christian Chabannon, Guillermo Puigventós, Romée Heemskerk, Isabel Sánchez-Ortega, Tuula Rintala, Yann Mahé, Emanuele Angelucci, Silvia Montoto, Michelle Kenyon, Hilda Mekelenkamp, Donal P. McLornan, Antonio M. Risitano, Mette Hazenberg, Anna Sureda, Ibrahim Yakoub Agha, Annalisa Ruggeri, Fabio Ciceri, Raffaella Greco

  • October 12, 2026

Related Content

Outcomes for American Indian and Alaska Native Populations With Cancer in Traditional Medicare

Author Correction: A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance

Improving survival and narrowing age disparities in mantle cell lymphoma across therapeutic eras